CTXR Projected Dividend Yield
Citius Pharmaceuticals Inc ( NASDAQ : CTXR )Citius Pharmaceuticals is a pharmaceutical company. Co. is developing the following products: Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, a IL-2 diphtheria toxin fusion protein for the treatment of patients with recurrent cutaneous T-cell lymphoma. 20 YEAR PERFORMANCE RESULTS |
CTXR Dividend History Detail CTXR Dividend News CTXR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |